Hans Preusting

Hans Preusting

Director/Board Member chez MENDUS AB

62 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Hans Preusting is an Independent Director at Mendus AB and a Chief Executive Officer at Synerkine Pharma BV.
He is on the Board of Directors at Mendus AB, DCPrime BV, Oxyrane UK Ltd.
and PharmaCell BV.
Dr. Preusting was previously employed as a Director-Operations & Business Development by Amsterdam Molecular Therapeutics (AMT) Holding NV, a Director-Influenza & Cell Culture Vaccine by Solvay Pharmaceuticals BV, a Manager-Operations by DSM Biologics Holding, Inc., and a Chief Business Officer by uniQure NV.
He received his MBA from Rotterdam School of Management and a doctorate degree from Rotterdam School of Management.

Postes actifs de Hans Preusting

SociétésPosteDébut
MENDUS AB Director/Board Member 01/01/2021
Director/Board Member -
Director/Board Member -
Chief Executive Officer -
Director/Board Member 01/04/2019
Tous les postes actifs de Hans Preusting

Anciens postes connus de Hans Preusting

SociétésPosteFin
Chief Operating Officer 11/03/2013
Corporate Officer/Principal 01/01/2006
Chief Operating Officer 01/01/2003
UNIQURE N.V. Chief Operating Officer 09/04/2014
Voir l'expérience en détail de Hans Preusting

Formation de Hans Preusting

Rotterdam School of Management Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hans Preusting

Relations

54

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MENDUS AB

Health Technology

UNIQURE N.V.

Health Technology

Entreprise privées7

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hans Preusting